RecruitingNot applicableNCT02910895

A Platform of Patient Derived Xenografts (PDX) and 2D/3D Cell Cultures of Soft Tissue Sarcomas (STS)

Studying Soft tissue sarcoma

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
The Netherlands Cancer Institute
Principal Investigator
Rick Haas, MD, PhD
The Netherlands Cancer Institute
Intervention
tumor biopsy(other)
Enrollment
40 enrolled
Eligibility
18 years · All sexes
Timeline
2017 – 2024

Study locations (1)

Collaborators

KU Leuven

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02910895 on ClinicalTrials.gov

Other trials for Soft tissue sarcoma

Additional recruiting or active studies for the same condition.

See all trials for Soft tissue sarcoma →

← Back to all trials